NGM BIOPHARMACEUTICALS INC financial data

Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2023 - 11 Mar 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83,462,408 shares 1.3%